Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019;9(3):449-465.
doi: 10.3233/JPD-199002.

CLINICAL TRIAL HIGHLIGHTS - DYSKINESIA

Kevin McFarthing  1 , Neha Prakash  2 , Tanya Simuni  2
Affiliations
Review

CLINICAL TRIAL HIGHLIGHTS - DYSKINESIA

Kevin McFarthing et al. J Parkinsons Dis. 2019.
No abstract available

PubMed Disclaimer

References

    1. Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, Bezard E, Picconi B, Calabresi P, Lang AE (2018) Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts. Ann. Neurol. 84, 797–811. - PubMed
    1. Hung SW, Adeli GM, Arenovich T, Fox SH, Lang AE (2010) Patient perception of dyskinesia in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 81, 1112–5. - PubMed
    1. Nadjar A, Gerfen CR, Bezard E (2009) Priming for l-dopa-induced dyskinesia in Parkinson’s disease: A feature inherent to the treatment or the disease? Prog. Neurobiol. 87, 1–9. - PMC - PubMed
    1. de la Fuente-Fernandez R, Sossi V, Huang Z, Furtado S, Lu J-Q, Calne DB, Ruth TJ, Stoessl AJ (2004) Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson’s disease: implications for dyskinesias. Brain 127, 2747–2754. - PubMed
    1. Porras G, De Deurwaerdere P, Li Q, Marti M, Morgenstern R, Sohr R, Bezard E, Morari M, Meissner WG (2014) L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum. Sci. Rep. 4, 3730. - PMC - PubMed

MeSH terms

Associated data